Pharmaceutical Company to Split Profits with Indigenous Donors of Genetic Material

0
ss5_p-200128962pv-1u-ngfpllsf3kjnibxllynev-repyrgdzccl4n1q5qu9g-1

Variant Bio, a Seattle-based biotech company, is leveraging genetic data from Indigenous populations to create treatments for obesity and diabetes.

Leave a Reply

Your email address will not be published. Required fields are marked *